Beyond numbers, quality in ADR reporting – New podcast episode

Research / 04 June 2025

Spontaneous adverse event reports pose significant challenges to pharmacovigilance scientists. How may we turn them into opportunities that benefit our pharmacovigilance systems?


Spontaneous adverse event reporting keeps the wheel of pharmacovigilance turning, but poses significant challenges that impact its efficacy. For one, only a fraction of adverse events are reported, and what is reported is of poor quality.

In this episode of Drug Safety Matters, Fredrik Brounéus is joined by Henry Zakumumpa, a researcher at Makerere University in Kampala, Uganda whose qualitative study on factors affecting adverse event reporting in the country has uncovered some surprising findings.

You may also like


Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

22 October 2024

A guide to reporting disproportionality analyses – New podcast episode

The READUS-PV statement is the first-ever guide for reports of disproportionality analyses that are replicable, reliable, and reproducible.

07 October 2024

Uncovering pregnancy cases in VigiBase

To tackle the lack of medicine and vaccine safety data for pregnant people, UMC has developed an algorithm to more easily identify pregnancy-related reports in VigiBase.

21 January 2025